Novabay Pharmaceuticals Share Price Today
(NASDAQ: NBY)

Name: Novabay Pharmaceuticals Share Price Today (NASDAQ: NBY) - Novabay Pharmaceuticals Stock Price Live Quote | INDmoney
Brand: INDmoney
Rating: 4.7 (371551 reviews)

Novabay Pharmaceuticals share price is $0.58 & ₹50.44 as on 6 Mar 2025, 2.30 'hrs' IST

$0.58

▲

-0.05

(-7.48%)

Market is closed - opens 8 PM, 06 Mar 2025

View live Novabay Pharmaceuticals share price in Dollar and Rupees. Guide to invest in Novabay Pharmaceuticals stock from India, including Indian investor sentiment. Get details on Indian mutual funds investing in Novabay Pharmaceuticals, along with analyst recommendations, forecasts, and comprehensive financials.

Novabay Pharmaceuticals share price movements

Today's Low: $0.58
Today's High: $0.63
$0.58
0.0%
Downside
Day's Volatility :7.91%
Upside
7.91%
52 Weeks Low: $0.36
52 Weeks High: $9.08
$0.58
37.74%
Downside
52 Weeks Volatility :96.02%
Upside
93.61%

Novabay Pharmaceuticals (NBY) Returns

Period	Novabay Pharmaceuticals Inc	Index (Russel 2000)
3 Months	8.96%	0.0%
6 Months	33.83%	0.0%
1 Year	-87.64%	0.0%
3 Years	-99.81%	-11.6%

Novabay Pharmaceuticals (NBY) Key Statistics

in dollars & INR

Previous Close	$0.6274
Open	$0.6
Today's High	$0.6298
Today's Low	$0.58
Market Capitalization	$2.8M
Today's Volume	$10.5K
52 Week High	$9.079
52 Week Low	$0.3611
Revenue TTM	$13.8M
EBITDA	$-5.4M
Earnings Per Share (EPS)	$-74.61
Profit Margin	-73.09%
Quarterly Earnings Growth YOY	0.0%
Return On Equity TTM	-273.8%

How to invest in Novabay Pharmaceuticals Stock (NBY) from India?

It is very easy for Indian residents to invest directly in Novabay Pharmaceuticals from India. Indian investors can open a free US stocks account on the INDmoney app. You can find live prices of the Novabay Pharmaceuticals stock in both Indian Rupees (INR) and US Dollars (USD). Search for Novabay Pharmaceuticals or NBY on the INDmoney app and click on Buy or SIP. You can invest by choosing quantities of shares of Novabay Pharmaceuticals or rupee/ dollar value or set up a fixed SIP amount to be invested every month or week.

For example: You can easily buy Rs.100 worth of Novabay Pharmaceuticals shares which would translate to 1.499 fractional shares of Novabay Pharmaceuticals as of today. Learn more about fractional investing.

Indians can now also easily transfer and add money to their US stocks account via the INDmoney app. Invest in US Stocks from India, including recognised companies like Novabay Pharmaceuticals, in just a few clicks!

Returns in Novabay Pharmaceuticals (NBY) for Indian investors in Rupees

The Novabay Pharmaceuticals stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

Investment Value

₹1,00,000

Novabay Pharmaceuticals investment value today

Current value as on today

₹16,380

Returns

₹83,620

(-83.62%)

Returns from Novabay Pharmaceuticals Stock

₹88,583 (-88.58%)

Dollar Returns

₹4,963 (+4.96%)

Indian investors sentiment towards Novabay Pharmaceuticals (NBY)

-48%

Period: Feb 3, 2025 to Mar 5, 2025. Change in 30 Days versus previous period

Search interest for Novabay Pharmaceuticals Stock from India on INDmoney has decreased by -48% in the last 30 days, reflecting a downward trend in search activity.

Analyst Recommendation on Novabay Pharmaceuticals

Buy

83%Buy

16%Hold

0%Sell

Based on 6 Wall street analysts offering stock ratings for Novabay Pharmaceuticals(by analysts ranked 0 to 5 stars)

Based on 6 analyst

Current
1M Ago
3M Ago

Buy

Hold

Sell

Analyst Forecast on Novabay Pharmaceuticals Stock (NBY)

What analysts predicted

Upside of 46.55%

Target:

$0.85

Current:

$0.58

Insights on Novabay Pharmaceuticals Stock (Ticker Symbol: NBY)

Price Movement
In the last 1 year, NBY stock has moved down by -87.9%
Increasing Revenue
Revenue is up for the last 2 quarters, 2.4M → 2.44M (in $), with an average increase of 1.7% per quarter
Increasing Net Profit
Netprofit is up for the last 4 quarters, -4.10M → -1.21M (in $), with an average increase of 53.8% per quarter
NBY vs ALNY (1 yr)
In the last 1 year, Alnylam Pharmaceuticals, Inc. has given 62.3% return, outperforming this stock by 150.2%
NBY vs VRTX (3 yr)
In the last 3 years, Vertex Pharmaceuticals Incorporated has given 47.7% return, outperforming this stock by 147.5%
Price to Sales
ForNBY every $1 of sales, investors are willing to pay $0.1, whereas for Alnylam Pharmaceuticals, Inc., the investors are paying $13.8 for every $1 of sales.

NBY Novabay Pharmaceuticals Financials in INR & Dollars

	FY18	Y/Y Change
Revenue	$12.5M	↓ 31.39%
Net Income	$-6.5M	↓ 11.59%
Net Profit Margin	-52.33%	↓ 11.72%

	FY19	Y/Y Change
Revenue	$6.6M	↓ 47.24%
Net Income	$-10.5M	↑ 60.23%
Net Profit Margin	-158.92%	↓ 106.59%

	FY20	Y/Y Change
Revenue	$9.9M	↑ 50.54%
Net Income	$-11.0M	↑ 5.26%
Net Profit Margin	-111.12%	↑ 47.8%

	FY21	Y/Y Change
Revenue	$8.4M	↓ 15.23%
Net Income	$-6.6M	↓ 40.58%
Net Profit Margin	-77.89%	↑ 33.23%

	FY22	Y/Y Change
Revenue	$14.4M	↑ 71.05%
Net Income	$-16.3M	↑ 147.98%
Net Profit Margin	-112.92%	↓ 35.03%

	FY23	Y/Y Change
Revenue	$14.7M	↑ 2.24%
Net Income	$-9.6M	↓ 40.73%
Net Profit Margin	-65.46%	↑ 47.46%

	Q2 FY23	Q/Q Change
Revenue	$4.6M	↑ 47.57%
Net Income	$-4.0M	↑ 131.86%
Net Profit Margin	-87.46%	↓ 31.79%

	Q3 FY23	Q/Q Change
Revenue	$3.3M	↓ 29.39%
Net Income	$-1.8M	↓ 56.42%
Net Profit Margin	-53.98%	↑ 33.48%

	Q4 FY23	Q/Q Change
Revenue	$3.7M	↑ 14.5%
Net Income	$-4.1M	↑ 133.81%
Net Profit Margin	-110.22%	↓ 56.24%

	Q1 FY24	Q/Q Change
Revenue	$2.6M	↓ 29.41%
Net Income	$-3.2M	↓ 21.76%
Net Profit Margin	-122.16%	↓ 11.94%

	Q2 FY24	Q/Q Change
Revenue	$2.4M	↓ 8.78%
Net Income	$-1.6M	↓ 50.68%
Net Profit Margin	-66.04%	↑ 56.12%

	Q3 FY24	Q/Q Change
Revenue	$2.4M	↑ 1.71%
Net Income	$-1.2M	↓ 23.53%
Net Profit Margin	-49.65%	↑ 16.39%

	FY18	Y/Y Change
Profit	$11.0M	↓ 28.75%

	FY19	Y/Y Change
Profit	$4.9M	↓ 55.83%

	FY20	Y/Y Change
Profit	$6.0M	↑ 22.69%

	FY21	Y/Y Change
Profit	$5.6M	↓ 5.35%

	FY22	Y/Y Change
Profit	$7.8M	↑ 37.84%

	FY23	Y/Y Change
Profit	$7.9M	↑ 1.47%

	Q2 FY23	Q/Q Change
Profit	$2.3M	↑ 19.11%

	Q3 FY23	Q/Q Change
Profit	$1.8M	↓ 20.29%

	Q4 FY23	Q/Q Change
Profit	$1.8M	↓ 1.25%

	Q1 FY24	Q/Q Change
Profit	$1.8M	↓ 1.16%

	Q2 FY24	Q/Q Change
Profit	$1.6M	↓ 11.26%

	Q3 FY24	Q/Q Change
Profit	$1.6M	↑ 0.06%

	FY18	Y/Y Change
Operating Cash Flow	$-5.6M	↓ 11.2%
Investing Cash Flow	$-44.0K	↓ 81.97%
Financing Cash Flow	$5.6M	↑ 2684.58%

	FY19	Y/Y Change
Operating Cash Flow	$-7.9M	↑ 42.4%
Investing Cash Flow	$-19.0K	↓ 56.82%
Financing Cash Flow	$11.7M	↑ 109.08%

	FY20	Y/Y Change
Operating Cash Flow	$-4.7M	↓ 40.46%
Investing Cash Flow	$-26.0K	↑ 36.84%
Financing Cash Flow	$9.8M	↓ 16.58%

	FY21	Y/Y Change
Operating Cash Flow	$-9.2M	↑ 94.7%
Investing Cash Flow	$-12.0M	↑ 46226.92%
Financing Cash Flow	$16.8M	↑ 71.98%

	FY22	Y/Y Change
Operating Cash Flow	$-6.7M	↓ 27.61%
Investing Cash Flow	$-112.0K	↓ 99.07%
Financing Cash Flow	$4.6M	↓ 72.4%

	Q2 FY23	Q/Q Change
Operating Cash Flow	$-1.8M	↑ 14.4%
Investing Cash Flow	$-15.0K	↑ 15.38%
Financing Cash Flow	$2.5M	-

Novabay Pharmaceuticals Technicals Summary

Sell

Neutral

Buy

Novabay Pharmaceuticals is currently not in a favorable trading position ( SELL ) according to technical analysis indicators.

Novabay Pharmaceuticals (NBY) Vs Peers

Company Name	1 Month	6 Month	1 Year	3 Years	5 Years
Novabay Pharmaceuticals Inc	-5.55%	33.83%	-87.64%	-99.81%	-99.89%
Regeneron Pharmaceuticals, Inc.	1.3%	-41.29%	-30.51%	9.2%	42.38%
Beone Medicines Ltd	15.19%	34.31%	61.3%	43.16%	68.1%
Vertex Pharmaceuticals Incorporated	3.37%	3.77%	18.06%	106.43%	121.36%
Alnylam Pharmaceuticals, Inc.	-11.52%	-3.4%	62.32%	49.04%	120.93%

Company Name	P/E Ratio	P/B Ratio	PEG Ratio	EPS	ROE	ROA	Div Yield	BVPS
Novabay Pharmaceuticals Inc	NA	NA	0.0	-3.26	-2.74	-0.42	NA	0.22
Regeneron Pharmaceuticals, Inc.	17.85	17.85	1.03	43.09	0.16	0.07	0.01	273.57
Beone Medicines Ltd	NA	NA	NA	1.43	-0.19	-0.06	NA	31.22
Vertex Pharmaceuticals Incorporated	32.84	NA	1.33	18.07	-0.03	0.13	NA	63.87
Alnylam Pharmaceuticals, Inc.	NA	NA	-0.49	0.57	-15.01	-0.03	NA	0.52

Company Name	Analyst View	Market Cap	5 Years Return %	PE Ratio	Profit Margin
Novabay Pharmaceuticals Inc	Buy	$2.8M	-99.89%	NA	-73.09%
Regeneron Pharmaceuticals, Inc.	Buy	$74.9B	42.38%	17.85	31.07%
Beone Medicines Ltd	NA	$28.5B	68.1%	NA	-16.92%
Vertex Pharmaceuticals Incorporated	Buy	$124.1B	121.36%	32.84	-4.86%
Alnylam Pharmaceuticals, Inc.	Buy	$31.5B	120.93%	NA	-12.37%

About Novabay Pharmaceuticals

NovaBay Pharmaceuticals, Inc. develops and sells eyecare and wound care products in the United States and internationally. It offers Avenova Spray, a solution for removing foreign materials, including microorganisms and debris from skin around the eye, such as the eyelid; Avenova Eye Health Support antioxidant-rich oral supplements; Avenova Lubricating Eye Drops for instant relief; NovaWipes by Avenova; Avenova WarmEye Compress to soothe the eyes; and the i-Chek by Avenova to monitor physical eyelid health. The company also provides wound care products, which are used for cleansing and irrigation as part of surgical procedures, as well as treating wounds, burns, ulcers, and other injuries under the NeutroPhase and PhaseOne brands. It sells its products through the company's web stores, third-party online retailers and distribution partners. The company was formerly known as NovaCal Pharmaceuticals, Inc. and changed its name to NovaBay Pharmaceuticals, Inc. in February 2007. NovaBay Pharmaceuticals, Inc. was incorporated in 2000 and is headquartered in Emeryville, California.

Organization	Novabay Pharmaceuticals
Employees	24
CEO	Mr. Justin M. Hall Esq.
Industry	Health Technology

Management People of Novabay Pharmaceuticals

Name	Title
Mr. Justin M. Hall Esq.	President, CEO, General Counsel, Chief Compliance Officer, Corporate Secretary & Director
Mr. Tommy Law	Controller, Interim CFO & Treasurer

Important FAQs about investing in NBY Stock from India :

What is Novabay Pharmaceuticals share price today?

Novabay Pharmaceuticals share price today stands at $0.58, Open: $0.60 ; Previous Close: $0.63 ; High: $0.63 ; Low: $0.58 ; 52 Week High: $9.08 ; 52 Week Low: $0.36.

The stock opens at $0.60, after a previous close of $0.63. The stock reached a daily high of $0.63 and a low of $0.58, with a 52-week high of $9.08 and a 52-week low of $0.36.

Can Indians buy Novabay Pharmaceuticals shares?

Yes, Indians can invest in the Novabay Pharmaceuticals (NBY) from India.

With INDmoney, you can buy Novabay Pharmaceuticals at 0 brokerage. The step-by-step process is as follows:

Open your zero cost US Stocks account and zero balance IND linked savings a/c (this can be done in less than 3 minutes)
Transfer funds to your US Stocks account using your IND linked savings a/c (It takes 24 hours excluding Saturday and Sunday). With INDmoney, you get the best INR USD exchange rates.
Once funds are transferred successfully, you can buy Novabay Pharmaceuticals at zero transaction cost.

How can I buy Novabay Pharmaceuticals shares from India?

It is very easy to buy Novabay Pharmaceuticals from India. With INDmoney, you can open a US stocks account in less than 3 minutes. Transfer funds in 24 hours and buy stocks very easily - that too at 0 brokerage. All this is done at 0 account opening & management fee, 0 brokerages, and at the same time you get the best rupee-US dollar exchange rate.

Can Fractional shares of Novabay Pharmaceuticals (NBY) be purchased?

Yes, you can buy fractional shares of Novabay Pharmaceuticals with INDmoney app.

What are the documents required to start investing in Novabay Pharmaceuticals stocks?

To start investing in Novabay Pharmaceuticals, You will need the following documents:

Proof of Identification (PAN, Aadhaar etc)
Proof of address (Aadhaar, Voter ID etc)

These documents are required as per RBI's guidelines to create your IND linked savings a/c so that you can execute for global fund transfer. The entire process is paperless and can be completed seamlessly.